Efficacy and Safety in Key Patient Subgroups of Nivolumab (Nivo) Alone Or Combined with Ipilimumab (Ipi) Versus Ipi Alone in Treatment-Naive Patients with Advanced Melanoma
Larkin, J Chiarion-Sileni, V Gonzalez, R Grob, J Cowey, C Lao, C Wagstaff, J Hogg, D Hill, A Carlino, M
Larkin, J
Chiarion-Sileni, V
Gonzalez, R
Grob, J
Cowey, C
Lao, C
Wagstaff, J
Hogg, D
Hill, A
Carlino, M
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Efficacy and Safety in Key Patient Subgroups of Nivolumab (Nivo) Alone Or Combined with Ipilimumab (Ipi) Versus Ipi Alone in Treatment-Naive Patients with Advanced Melanoma. 2015, 11: 126 Asia-Pacific Journal of Clinical Oncology